Identification of novel PTP1B inhibitors by pharmacophore based virtual screening, scaffold hopping and docking

Ligand and structure-based design followed by prioritization through virtual screening and synthesis has led to the identification of compound 115 as novel orally bioavailable PTP1B inhibitor.